These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513 [TBL] [Abstract][Full Text] [Related]
4. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China. Yan X; Hu HT; Liu S; Sun YH; Gao X Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471 [TBL] [Abstract][Full Text] [Related]
8. Would a Large tPA Trial for Those 4.5 to 6.0 Hours from Stroke Onset Be Good Value for Information? Soeteman DI; Menzies NA; Pandya A Value Health; 2017; 20(7):894-901. PubMed ID: 28712618 [TBL] [Abstract][Full Text] [Related]
9. Vascular Risk Factors in Patients with Different Subtypes of Ischemic Stroke May Affect Their Outcome after Intravenous tPA. Dong Y; Cao W; Ren J; Nair DS; Parker S; Jahnel JL; Swanson-Devlin TG; Beck JM; Mathews M; McNeil CJ; Upadhyaya M; Gao Y; Dong Q; Wang DZ PLoS One; 2015; 10(8):e0131487. PubMed ID: 26247772 [TBL] [Abstract][Full Text] [Related]
10. The totaled health risks in vascular events (THRIVE) score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA trial. Kamel H; Patel N; Rao VA; Cullen SP; Faigeles BS; Smith WS; Flint AC J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1111-6. PubMed ID: 23122722 [TBL] [Abstract][Full Text] [Related]
11. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator. Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916 [TBL] [Abstract][Full Text] [Related]
12. Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. NINDS; The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. Stroke; 2000 Dec; 31(12):2912-9. PubMed ID: 11108748 [TBL] [Abstract][Full Text] [Related]
13. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients. Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014 [TBL] [Abstract][Full Text] [Related]
14. Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older : the tPA stroke survey experience. Tanne D; Gorman MJ; Bates VE; Kasner SE; Scott P; Verro P; Binder JR; Dayno JM; Schultz LR; Levine SR Stroke; 2000 Feb; 31(2):370-5. PubMed ID: 10657408 [TBL] [Abstract][Full Text] [Related]
15. Safety of air medical transportation after tissue plasminogen activator administration in acute ischemic stroke. Chalela JA; Kasner SE; Jauch EC; Pancioli AM Stroke; 1999 Nov; 30(11):2366-8. PubMed ID: 10548672 [TBL] [Abstract][Full Text] [Related]
16. Increase in neutrophils after recombinant tissue plasminogen activator thrombolysis predicts poor functional outcome of ischaemic stroke: a longitudinal study. Shi J; Peng H; You S; Liu Y; Xu J; Xu Y; Liu H; Shi R; Cao Y; Liu CF Eur J Neurol; 2018 Apr; 25(4):687-e45. PubMed ID: 29341345 [TBL] [Abstract][Full Text] [Related]
17. Streamlined Hyperacute Magnetic Resonance Imaging Protocol Identifies Tissue-Type Plasminogen Activator-Eligible Stroke Patients When Clinical Impression Is Stroke Mimic. Goyal MS; Hoff BG; Williams J; Khoury N; Wiesehan R; Heitsch L; Panagos P; Vo KD; Benzinger T; Derdeyn CP; Lee JM; Ford AL Stroke; 2016 Apr; 47(4):1012-7. PubMed ID: 26892282 [TBL] [Abstract][Full Text] [Related]